Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?

Rossella E. Nappi, Laura Cucinella, Lara Tiranini, Ellis Martini

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)421-423
Number of pages3
JournalExpert Opinion on Pharmacotherapy
Volume19
Issue number5
DOIs
Publication statusPublished - Mar 24 2018

Keywords

  • female sexual dysfunction (FSD)
  • flibanserin
  • hormone therapy (HT)
  • hypoactive sexual desire disorder (HSDD)
  • PDE5 inhibitors
  • psychoactive drugs
  • Sexual medicine

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? / Nappi, Rossella E.; Cucinella, Laura; Tiranini, Lara; Martini, Ellis.

In: Expert Opinion on Pharmacotherapy, Vol. 19, No. 5, 24.03.2018, p. 421-423.

Research output: Contribution to journalEditorial

@article{672b4cda353240ca840c79bd12c4b770,
title = "Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?",
keywords = "female sexual dysfunction (FSD), flibanserin, hormone therapy (HT), hypoactive sexual desire disorder (HSDD), PDE5 inhibitors, psychoactive drugs, Sexual medicine",
author = "Nappi, {Rossella E.} and Laura Cucinella and Lara Tiranini and Ellis Martini",
year = "2018",
month = "3",
day = "24",
doi = "10.1080/14656566.2018.1444751",
language = "English",
volume = "19",
pages = "421--423",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?

AU - Nappi, Rossella E.

AU - Cucinella, Laura

AU - Tiranini, Lara

AU - Martini, Ellis

PY - 2018/3/24

Y1 - 2018/3/24

KW - female sexual dysfunction (FSD)

KW - flibanserin

KW - hormone therapy (HT)

KW - hypoactive sexual desire disorder (HSDD)

KW - PDE5 inhibitors

KW - psychoactive drugs

KW - Sexual medicine

UR - http://www.scopus.com/inward/record.url?scp=85042939211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042939211&partnerID=8YFLogxK

U2 - 10.1080/14656566.2018.1444751

DO - 10.1080/14656566.2018.1444751

M3 - Editorial

VL - 19

SP - 421

EP - 423

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 5

ER -